Genetic Diagnostic Centre

Genetic Diagnostic Center is a leading Egyptian medical center dedicated to delivering innovative medical genetics services for patients and other healthcare providers. In GDC, we combine 50 years of experience with the latest cutting-edge technologies to offer a quality driven performance in Cytogenetics, Molecular Genetics, Hematopathology, Flow Cytometry and Immunohistochemistry.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

INDUSTRIAL IMPACT

PORTAL INNOVATIONS EXPANDS CHICAGO OPERATIONS TRIPLES SPACE IN FULTON LABS

Portal Innovations | February 03, 2022

news image

Portal Innovations continues its momentum in Chicago by launching the second phase of its operations with the opening of 35,000 square feet of premier wet and dry lab and office space at 400 North Aberdeen in Fulton Labs. The new facility will allow Portal, a life sciences venture development engine, to grow and scale its investment in early-stage biotech companies in Chicago. Portal has tapped Patrick Flavin to serve as President of its flagship Chicago operation. With over 20 ye...

Read More

FRED HUTCH MANDATES REMOTE WORKING TO CURB COVID-19

FierceBiotech | March 06, 2020

news image

The Fred Hutchinson Cancer Research Center is making its Seattle-based staff work from home in light of the emergence of a cluster of coronavirus cases in the city. The precautionary action comes as biopharma companies are starting to pull back from face-to-face events to cut the risk of their employees catching the virus. As of Thursday, all of Fred Hutch’s Seattle-based employees, bar security and other staff that need to be on campus, are working remotely. Fred Hutch plans to keep the m...

Read More

FUJIFILM DIOSYNTH BIOTECHNOLOGIES ENTERS STRATEGIC PARTNERSHIP WITH OXGENE™ TO ADDRESS SUPPLY BOTTLENECKS IN GENE THERAPY DEVELOPMENT & MANUFACTURING

FUJIFILM Diosynth Biotechnologies | April 23, 2020

news image

FUJIFILM Diosynth Biotechnologies (FDB), a world leading cGMP Contract Development and Manufacturing Organization (CDMO) supporting its partners in the biopharmaceutical industry with the development and production of their biologics, vaccines and gene therapies, announced a strategic partnership with OXGENE™, an industry leader in the design and development of gene therapy technologies. This partnership will enable FDB to deliver gene therapy products to clients with an approximate 25% le...

Read More

MEDICAL

GENSCRIPT LAUNCHES GMP SINGLE-STRAND AND DOUBLE-STRAND DNA SERVICE FOR SUPPORTING GENE AND CELL THERAPY DEVELOPMENT

GenScript | May 18, 2022

news image

GenScript USA Inc., the world's leading life-science research tools and services provider, announced the availability of new GMP-grade GenExact™ single-stranded DNA (ssDNA) and GenWand™ closed-end linear double-stranded DNA (dsDNA) services. These services will enable next-generation gene and cell therapy R&D programs to advance to IND filing and clinical trials faster and more efficiently. Today's announcement, made at the American Society of Gene & Ce...

Read More
news image

INDUSTRIAL IMPACT

PORTAL INNOVATIONS EXPANDS CHICAGO OPERATIONS TRIPLES SPACE IN FULTON LABS

Portal Innovations | February 03, 2022

Portal Innovations continues its momentum in Chicago by launching the second phase of its operations with the opening of 35,000 square feet of premier wet and dry lab and office space at 400 North Aberdeen in Fulton Labs. The new facility will allow Portal, a life sciences venture development engine, to grow and scale its investment in early-stage biotech companies in Chicago. Portal has tapped Patrick Flavin to serve as President of its flagship Chicago operation. With over 20 ye...

Read More
news image

FRED HUTCH MANDATES REMOTE WORKING TO CURB COVID-19

FierceBiotech | March 06, 2020

The Fred Hutchinson Cancer Research Center is making its Seattle-based staff work from home in light of the emergence of a cluster of coronavirus cases in the city. The precautionary action comes as biopharma companies are starting to pull back from face-to-face events to cut the risk of their employees catching the virus. As of Thursday, all of Fred Hutch’s Seattle-based employees, bar security and other staff that need to be on campus, are working remotely. Fred Hutch plans to keep the m...

Read More
news image

FUJIFILM DIOSYNTH BIOTECHNOLOGIES ENTERS STRATEGIC PARTNERSHIP WITH OXGENE™ TO ADDRESS SUPPLY BOTTLENECKS IN GENE THERAPY DEVELOPMENT & MANUFACTURING

FUJIFILM Diosynth Biotechnologies | April 23, 2020

FUJIFILM Diosynth Biotechnologies (FDB), a world leading cGMP Contract Development and Manufacturing Organization (CDMO) supporting its partners in the biopharmaceutical industry with the development and production of their biologics, vaccines and gene therapies, announced a strategic partnership with OXGENE™, an industry leader in the design and development of gene therapy technologies. This partnership will enable FDB to deliver gene therapy products to clients with an approximate 25% le...

Read More
news image

MEDICAL

GENSCRIPT LAUNCHES GMP SINGLE-STRAND AND DOUBLE-STRAND DNA SERVICE FOR SUPPORTING GENE AND CELL THERAPY DEVELOPMENT

GenScript | May 18, 2022

GenScript USA Inc., the world's leading life-science research tools and services provider, announced the availability of new GMP-grade GenExact™ single-stranded DNA (ssDNA) and GenWand™ closed-end linear double-stranded DNA (dsDNA) services. These services will enable next-generation gene and cell therapy R&D programs to advance to IND filing and clinical trials faster and more efficiently. Today's announcement, made at the American Society of Gene & Ce...

Read More